{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:16:58Z","timestamp":1789402618575,"version":"build-2803163510"},"reference-count":84,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Chloramphenicol is an old broad-spectrum antibiotic. We assessed its efficacy and safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a systematic review and meta-analysis. Electronic databases were searched to identify randomized controlled trials (RCTs) that assessed patients, of any age, with systemic bacterial infections that can cause sepsis and compared chloramphenicol alone versus other antibiotics. No restrictions on the date of publication, language or publication status were applied. The primary outcome assessed was overall mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty-six RCTs fulfilled the inclusion criteria, and these included 9711 patients. We found a higher mortality with chloramphenicol for respiratory tract infections [risk ratio (RR) 1.40, 95% CI 1.00\u20131.97] and meningitis (RR 1.27, 95% CI 1.00\u20131.60), both without heterogeneity. The point estimate was similar for enteric fever, without statistical significance. No statistically significant difference was found between chloramphenicol and other antibiotics regarding treatment failure, except for enteric fever (RR 1.46, 95% CI 1.07\u20132.00, without heterogeneity). This difference derived mainly from studies comparing chloramphenicol with fluoroquinolones (RR 1.85, 95% CI 1.07\u20133.2). There were no statistically significant differences between chloramphenicol and other antibiotics in terms of adverse events, including haematological events, except for anaemia, which occurred more frequently with chloramphenicol (RR 2.80, 95% CI 1.65\u20134.75, I2\u200a=\u200a0%), and gastrointestinal side effects, which were less frequent with chloramphenicol (RR 0.67, 95% CI 0.46\u20130.99, I2\u200a=\u200a0%). Many of the studies included were sponsored by pharmaceutical companies marketing the comparator drug to chloramphenicol, and this might have influenced the results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Chloramphenicol cannot be recommended as a first-line treatment for respiratory tract infections, meningitis or enteric fever as alternatives are probably more effective. Chloramphenicol is as safe as treatment alternatives for short antibiotic courses. RCTs are needed to test this treatment against MDR organisms when better alternatives do not exist.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dku530","type":"journal-article","created":{"date-parts":[[2015,1,12]],"date-time":"2015-01-12T21:23:25Z","timestamp":1421097805000},"page":"979-996","source":"Crossref","is-referenced-by-count":82,"title":["Efficacy and safety of chloramphenicol: joining the revival of old antibiotics? Systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1093","volume":"70","author":[{"given":"Noa","family":"Eliakim-Raz","sequence":"first","affiliation":[{"name":"1 \u00a0Department of Medicine E, Rabin Medical Center, Beilinson Hospital, Petah-Tiqva, Israel"},{"name":"2 \u00a0Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel"},{"name":"3 \u00a0Unit of Infectious Diseases, Rabin Medical Center, Beilinson Hospital, Petah-Tiqva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Lador","sequence":"additional","affiliation":[{"name":"1 \u00a0Department of Medicine E, Rabin Medical Center, Beilinson Hospital, Petah-Tiqva, Israel"},{"name":"2 \u00a0Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaara","family":"Leibovici-Weissman","sequence":"additional","affiliation":[{"name":"2 \u00a0Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel"},{"name":"4 \u00a0Department of Medicine D, Rabin Medical Center, Beilinson Hospital, Petah-Tiqva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Elbaz","sequence":"additional","affiliation":[{"name":"1 \u00a0Department of Medicine E, Rabin Medical Center, Beilinson Hospital, Petah-Tiqva, Israel"},{"name":"2 \u00a0Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mical","family":"Paul","sequence":"additional","affiliation":[{"name":"2 \u00a0Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel"},{"name":"5 \u00a0Unit of Infectious Diseases, Rambam Hospital, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Leibovici","sequence":"additional","affiliation":[{"name":"1 \u00a0Department of Medicine E, Rabin Medical Center, Beilinson Hospital, Petah-Tiqva, Israel"},{"name":"2 \u00a0Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,1,11]]},"reference":[{"key":"2022020121021848000_DKU530C1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/MCC.0b013e32827851d7","article-title":"Old antibiotics for infections in critically ill patients","volume":"13","author":"Falagas","year":"2007","journal-title":"Curr Opin Crit Care"},{"key":"2022020121021848000_DKU530C2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2174\/138945009789108846","article-title":"Role of antibiotics in multidrug resistant bacterial infections","volume":"10","author":"Maviglia","year":"2009","journal-title":"Curr Trug Targets"},{"key":"2022020121021848000_DKU530C3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/AAC.14.3.439","article-title":"High-performance liquid chromatographic assay of chloramphenicol in serum","volume":"14","author":"Koup","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"2022020121021848000_DKU530C4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0022-3565(25)03696-1","article-title":"Biochemical studies on chloramphenicol; tissue distribution and excretion studies","volume":"96","author":"Glazko","year":"1949","journal-title":"J Pharmacol Exp Ther"},{"key":"2022020121021848000_DKU530C5","volume-title":"Antimicrobial chemotherapy: antimicrobial inhibitors of ribosome function. In: Baron S et al., eds. Baron's Medical Microbiology","author":"Neu","edition":"2nd edn"},{"key":"2022020121021848000_DKU530C6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/bmj.333.7558.78","article-title":"Current concepts in the diagnosis and treatment of typhoid fever","volume":"333","author":"Bhutta","year":"2006","journal-title":"BMJ"},{"key":"2022020121021848000_DKU530C7","first-page":"416","article-title":"Untreatable infections?\u2013The challenge of the 21st century","volume":"29","author":"Parry","year":"1998","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"2022020121021848000_DKU530C8","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1093\/cid\/cit563","article-title":"Trends of etiology and drug resistance in enteric fever in the last two decades in Nepal: a systematic review and meta-analysis","volume":"57","author":"Karki","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2022020121021848000_DKU530C9","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0140-6736(67)92720-1","article-title":"The bacterial degradation of chloramphenicol","volume":"1","author":"Holt","year":"1967","journal-title":"Lancet"},{"key":"2022020121021848000_DKU530C10","volume-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","author":"Brunton","year":"2011","edition":"12th edn"},{"key":"2022020121021848000_DKU530C11","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Higgins","year":"2011"},{"key":"2022020121021848000_DKU530C12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/bmj.39421.435949.BE","article-title":"Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2\u201359 months in low resource settings: multicentre randomised controlled trial (SPEAR study)","volume":"336","author":"Asghar","year":"2008","journal-title":"BMJ"},{"key":"2022020121021848000_DKU530C13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0007-0971(72)90017-4","article-title":"Chloramphenicol and ampicillin compared in elderly patients with severe purulent exacerbations of bronchitis","volume":"66","author":"Pines","year":"1972","journal-title":"Br J Dis Chest"},{"key":"2022020121021848000_DKU530C14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0007-0971(72)90016-2","article-title":"Antibiotic regimens in moderately ill patients with purulent exacerbations of chronic bronchitis","volume":"66","author":"Pines","year":"1972","journal-title":"Br J Dis Chest"},{"key":"2022020121021848000_DKU530C15","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0140-6736(02)07677-8","article-title":"Chloramphenicol versus benzylpenicillin and gentamicin for the treatment of severe pneumonia in children in Papua New Guinea: a randomised trial","volume":"359","author":"Duke","year":"2002","journal-title":"Lancet"},{"key":"2022020121021848000_DKU530C16","first-page":"169","article-title":"Cefatrizine therapy in respiratory infections: clinical activity and effects on secretory IgAs","volume":"7","author":"Cogo","year":"1990","journal-title":"Advances in Therapy"},{"key":"2022020121021848000_DKU530C17","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0140-6736(91)91511-R","article-title":"Long-acting chloramphenicol versus intravenous ampicillin for treatment of bacterial meningitis","volume":"338","author":"P\u00e9coul","year":"1991","journal-title":"Lancet"},{"key":"2022020121021848000_DKU530C18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/bmj.3.5876.379","article-title":"Trial of chloramphenicol for meningitis in northern savanna of Africa","volume":"3","author":"Whittle","year":"1973","journal-title":"Br Med J"},{"key":"2022020121021848000_DKU530C19","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(89)92685-8","article-title":"Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group","volume":"1","author":"Peltola","year":"1989","journal-title":"Lancet"},{"key":"2022020121021848000_DKU530C20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0140-6736(05)66792-X","article-title":"Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study","volume":"366","author":"Nathan","year":"2005","journal-title":"Lancet"},{"key":"2022020121021848000_DKU530C21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/infdis\/125.5.459","article-title":"Treatment of Hemophilus influenzae meningitis: a comparison of chloramphenicol and tetracycline","volume":"125","author":"Nelson","year":"1972","journal-title":"J Infect Dis"},{"key":"2022020121021848000_DKU530C22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF01833875","article-title":"Pefloxacin versus chloramphenicol in the therapy of typhoid fever","volume":"23","author":"Cristiano","year":"1995","journal-title":"Infection"},{"key":"2022020121021848000_DKU530C23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/bmj.3.5718.320","article-title":"Evaluation of therapeutic efficacy of trimethoprim-sulphamethoxazole and chloramphenicol in enteric fever","volume":"3","author":"Kamat","year":"1970","journal-title":"Br Med J"},{"key":"2022020121021848000_DKU530C24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jac\/9.5.405","article-title":"Randomised, comparative trial of mecillinam, mecillinam\/ampicillin and chloramphenicol in the treatment of enteric fever","volume":"9","author":"Limson","year":"1982","journal-title":"J Antimicrob Chemother"},{"key":"2022020121021848000_DKU530C25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000238550","article-title":"Cefoperazone compared with chloramphenicol in the treatment of typhoid fever","volume":"34","author":"Morelli","year":"1988","journal-title":"Chemotherapy"},{"key":"2022020121021848000_DKU530C26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/infdis\/153.2.272","article-title":"Typhoid fever: successful therapy with cefoperazone","volume":"153","author":"Pape","year":"1986","journal-title":"J Infect Dis"},{"key":"2022020121021848000_DKU530C27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(75)92776-2","article-title":"Comparative trial of amoxycillin and chloramphenicol in treatment of typhoid fever in adults","volume":"7930","author":"Pillay","year":"1975","journal-title":"Lancet"},{"key":"2022020121021848000_DKU530C28","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/bmj.2.5472.1226","article-title":"Treatment of typhoid fever: a comparative trial of ampicillin and chloramphenicol","volume":"5472","author":"Sanders","year":"1965","journal-title":"Br Med J"},{"key":"2022020121021848000_DKU530C29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJM196801252780401","article-title":"Evaluation of chloramphenicol and ampicillin in salmonella enteric fever","volume":"278","author":"Robertson","year":"1968","journal-title":"NEJM"},{"key":"2022020121021848000_DKU530C30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/030006057900700314","article-title":"Comparative clinical trial of amoxicillin and chloramphenicol in the treatment of typhoid in adults","volume":"7","author":"Abengowe","year":"1979","journal-title":"J Int Med Res"},{"key":"2022020121021848000_DKU530C31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4269\/ajtmh.1995.52.162","article-title":"Treatment of typhoid fever: randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol","volume":"52","author":"Acharya","year":"1995","journal-title":"Am J Trop Med Hvg"},{"key":"2022020121021848000_DKU530C32","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/bmj.3.5620.721","article-title":"Trimethoprim and sulphamethoxazole in typhoid","volume":"5620","author":"Akinkugbe","year":"1968","journal-title":"Br Med J"},{"key":"2022020121021848000_DKU530C33","doi-asserted-by":"crossref","first-page":"195S","DOI":"10.1016\/S0002-9343(20)31164-5","article-title":"Randomized comparative study of fleroxacin and chloramphenicol in typhoid fever","volume":"94","author":"Arnold","year":"1993","journal-title":"Am J Med"},{"key":"2022020121021848000_DKU530C34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/00365528909091327","article-title":"Furazolidone and chloramphenicol for treatment of typhoid fever","volume":"169","author":"Carcelen","year":"1989","journal-title":"Scand J Gastroenterol Suppl"},{"key":"2022020121021848000_DKU530C35","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/clinids\/4.2.551","article-title":"response of typhoid fever caused by chloramphenicol-susceptible and chloramphenicol-resistant strains of Salmonella Typhi to treatment with trimethoprim-sulfamethoxazole","volume":"4","author":"Butler","year":"1982","journal-title":"Rev Infect Dis"},{"key":"2022020121021848000_DKU530C36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/44.2.243","article-title":"Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India","volume":"44","author":"Butler","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"2022020121021848000_DKU530C37","first-page":"1286","article-title":"Double blind trial with chloramphenicol and the combination trimethoprim\/sulfamethoxazole in typhoid","volume":"46","author":"Cardoso","year":"1972","journal-title":"S Afr Med J"},{"key":"2022020121021848000_DKU530C38","first-page":"131","article-title":"A comparative trial of furazolidone and chloramphenicol in typhoid fever","volume":"55","author":"Damany","year":"1970","journal-title":"J Indian Med Assoc"},{"key":"2022020121021848000_DKU530C39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/00365529309096065","article-title":"Randomized clinical trial of furazolidone for typhoid fever in children","volume":"28","author":"Dutta","year":"1993","journal-title":"Scand J Gastroenterol"},{"key":"2022020121021848000_DKU530C40","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1128\/AAC.47.5.1727-1731.2003","article-title":"Persistence of salmonellae in blood and bone marrow: randomized controlled trial comparing ciprofloxacin and chloramphenicol treatments against enteric fever","volume":"47","author":"Gasem","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2022020121021848000_DKU530C41","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1128\/AAC.38.3.558","article-title":"Randomized comparison of aztreonam and chloramphenicol in treatment of typhoid fever","volume":"3","author":"Gotuzzo","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"2022020121021848000_DKU530C42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1749-6632.1967.tb50241.x","article-title":"Comparison of parental ampicillin and parental chloramphenicol in the treatment of typhoid fever","volume":"145","author":"Kaye","year":"1967","journal-title":"Ann N Y Acad Sci"},{"key":"2022020121021848000_DKU530C43","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jac\/28.5.765","article-title":"Three-day treatment of typhoid fever with two different doses of ceftriaxone, compared to 14-day therapy with chloramphenicol: a randomized trial","volume":"28","author":"Lasserre","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"2022020121021848000_DKU530C44","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/0035-9203(73)90043-6","article-title":"Treatment of epidemic typhus. A comparative study of chloramphenicol, trimethoprim-sulphamethoxazole and doxycycline","volume":"67","author":"Huys","year":"1973","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2022020121021848000_DKU530C45","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/00007611-199712000-00008","article-title":"Cefixime: an oral option for the treatment of multidrug-resistant enteric fever in children","volume":"90","author":"Memon","year":"1997","journal-title":"South Med J"},{"key":"2022020121021848000_DKU530C46","first-page":"162","article-title":"Trimethoprim sulphamethoxazole in the treatment of enteric fever","volume":"78","author":"Omer Ali","year":"1975","journal-title":"J Trop Med Hyg"},{"key":"2022020121021848000_DKU530C47","first-page":"163","article-title":"A comparative study of cefixime and chloramphenicol in children with typhoid fever","volume":"48","author":"Rabbani","year":"1998","journal-title":"J Pak Med Assoc"},{"key":"2022020121021848000_DKU530C48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.trstmh.2004.08.007","article-title":"A randomized comparison of oral chloramphenicol versus ofloxacin in the treatment of uncomplicated typhoid fever in Laos","volume":"99","author":"Phongmany","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2022020121021848000_DKU530C49","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1473-3099(11)70089-5","article-title":"Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial","volume":"11","author":"Arjyal","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"2022020121021848000_DKU530C50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.1.5845.82","article-title":"Comparative trial of co-trimoxazole and chloramphenicol in typhoid fever","volume":"1","author":"Sardesai","year":"1973","journal-title":"Br Med J"},{"key":"2022020121021848000_DKU530C51","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/0035-9203(91)90390-K","article-title":"Randomized treatment of patients with typhoid and paratyphoid fevers using norfloxacin and chloramphenicol","volume":"85","author":"Sarma","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2022020121021848000_DKU530C52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/pgmj.40.Suppl.87","article-title":"Comparison of ampicillin and chloramphenicol in treatment of typhoid fever","volume":"40","author":"Scioli","year":"1964","journal-title":"Postgrad Med J"},{"key":"2022020121021848000_DKU530C53","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0924-8579(02)00388-6","article-title":"Treatment of typhoid fever in children with a flexible-duration of ceftriaxone, compared with 14-day treatment with chloramphenicol","volume":"21","author":"Tatli","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"2022020121021848000_DKU530C54","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/infdis\/128.Supplement_3.S734","article-title":"Trimethoprim-sulfamethoxazole in the treatment of typhoid and paratyphoid fevers","volume":"128","author":"Snyder","year":"1973","journal-title":"J Infect Dis"},{"key":"2022020121021848000_DKU530C55","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(76)91678-0","article-title":"Comparative efficacy of chloramphenicol, ampicillin, and co-trimoxazole in the treatment of typhoid fever","volume":"2","author":"Snyder","year":"1976","journal-title":"Lancet"},{"key":"2022020121021848000_DKU530C56","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1128\/AAC.37.8.1572","article-title":"Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial","volume":"37","author":"Islam","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"2022020121021848000_DKU530C57","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/infdis\/158.4.742","article-title":"Randomized treatment of patients with typhoid fever by using ceftriaxone or chloramphenicol","volume":"158","author":"Islam","year":"1988","journal-title":"J Infect Dis"},{"key":"2022020121021848000_DKU530C58","article-title":"Comparative double blind efficacy and safety study of ciprofloxacin with chloramphenicol in the treatment of typhoid fever","author":"Quintero-Perez"},{"key":"2022020121021848000_DKU530C59","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00006454-198910000-00007","article-title":"Once daily ceftriaxone vs. chloramphenicol for treatment of typhoid fever in children","volume":"8","author":"Moosa","year":"1989","journal-title":"Pediatr Infect Dis J"},{"key":"2022020121021848000_DKU530C60","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00006454-199001000-00010","article-title":"Comparative efficacies of aztreonam and chloramphenicol in children with typhoid fever","volume":"9","author":"Tanaka-Kido","year":"1990","journal-title":"Pediatr Infect Dis J"},{"key":"2022020121021848000_DKU530C61","first-page":"197","article-title":"Aztreonam compared to chloramphenicol in the treatment of enteric fevers","volume":"18","author":"Girgis","year":"1992","journal-title":"Drugs Exp Clin Res"},{"key":"2022020121021848000_DKU530C62","first-page":"607","article-title":"Ceftriaxone versus chloramphenicol in the treatment of enteric fever","volume":"16","author":"Girgis","year":"1990","journal-title":"Drugs Exp Clin Res"},{"key":"2022020121021848000_DKU530C63","first-page":"573","article-title":"A double blind study of chloramphenicol, furazolidine and combination regimens in enteric fevers","volume":"26","author":"Gupta","year":"1978","journal-title":"J Assoc Physicians India"},{"key":"2022020121021848000_DKU530C64","first-page":"709","article-title":"The efficacy of epicillin in enteric fever (a comparative study with that of chloramphenicol)","volume":"25","author":"Thiruvengadam","year":"1977","journal-title":"J Assoc Physicians India"},{"key":"2022020121021848000_DKU530C65","first-page":"36","article-title":"A comparative trial of co-trimoxazole and chloramphenicol in thyphoid and paratyphoid fever","volume":"81","author":"Ramachandran","year":"1978","journal-title":"J Trop Med Hyg"},{"key":"2022020121021848000_DKU530C66","first-page":"259","article-title":"Enteric fevers in children\u2014a prospective study on comparative evaluation of three drugs (chloramphenicol, furazolidone and co-trimethoxazole)","volume":"16","author":"Mahapatra","year":"1979","journal-title":"Indian Pediatr"},{"key":"2022020121021848000_DKU530C67","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/030006057700500203","article-title":"A comparative study of epicillin and chloramphenicol in the treatment of enteric fever","volume":"5","author":"Hassau","year":"1977","journal-title":"J Int Med Res"},{"key":"2022020121021848000_DKU530C68","first-page":"769","article-title":"A comparative study of chloramphenicol and furazolidone in the treatment of typhoid fever in children","volume":"15","author":"Punjani","year":"1978","journal-title":"Indian Pediatr"},{"key":"2022020121021848000_DKU530C69","first-page":"50","article-title":"A comparative evaluation of the treatment of typhoid fevers with co-trimoxazole and chloramphenicol in Egypt","volume":"78","author":"Hassan","year":"1975","journal-title":"J Trop Med Hyg"},{"key":"2022020121021848000_DKU530C70","first-page":"8","article-title":"Comparative study of fleroxacin vs. chloramphenicol in typhoid fever at San Lazaro Hospital","volume":"22","author":"Abejar","year":"1993","journal-title":"Phil J Microbiol Infect Dis"},{"key":"2022020121021848000_DKU530C71","first-page":"327","article-title":"Fleroxacin vs chloramphenicol in enteric fever. An open, randomized, parallel study","volume":"6","author":"Abejar","year":"1993","journal-title":"Phil J Intern Med"},{"key":"2022020121021848000_DKU530C72","first-page":"159","article-title":"A comparative trial of furazolidone and chloramphenicol in typhoid and paratyphoid fever","volume":"15","author":"Salgado","year":"1970","journal-title":"Ceylon Med J"},{"key":"2022020121021848000_DKU530C73","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/inf.1975.7.issue-2.08","article-title":"Co-trimoxazole compared to chloramphenicol in the treatment of enteric fever","volume":"7","author":"Uwaydah","year":"1975","journal-title":"Scand J Infect Dis"},{"key":"2022020121021848000_DKU530C74","first-page":"577","article-title":"Comparative clinical trial of co-trimoxazole, furazolidone and chloramphenicol in enteric fever","volume":"23","author":"Samantaray","year":"1975","journal-title":"J Assoc Physicians India"},{"key":"2022020121021848000_DKU530C75","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0011-393X(05)80459-X","article-title":"Fluoroquinolones versus chloramphenicol in the therapy of typhoid fever: a clinical and microbiological study","volume":"4","author":"Morelli","year":"1992","journal-title":"Curr Ther Res Clin Exp"},{"key":"2022020121021848000_DKU530C76","first-page":"39","article-title":"A comparison of the efficacy of trimethoprim-sulfamethoxazole (Bactrim) and chloramphenicol in the treatment of typhoid fever","volume":"2","author":"Siasoco","year":"1973","journal-title":"Phil J Microbiol Infect Dis"},{"key":"2022020121021848000_DKU530C77","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1086\/321864","article-title":"Efficacy and safety of clarithromycin as treatment for Mediterranean spotted fever in children: a randomized controlled trial","volume":"33","author":"Cascio","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2022020121021848000_DKU530C78","volume-title":"Standardized Treatment of Bacterial Meningitis in Africa in Epidemic and Non Epidemic Situations","author":"WHO"},{"key":"2022020121021848000_DKU530C79","volume-title":"Background Document: The Diagnosis, Treatment and Prevention of Typhoid Fever","author":"WHO"},{"key":"2022020121021848000_DKU530C80","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1128\/JCM.39.10.3727-3732.2001","article-title":"Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study","volume":"39","author":"Fluit","year":"2001","journal-title":"J Clin Microbiol"},{"key":"2022020121021848000_DKU530C81","first-page":"371","article-title":"Is chloramphenicol making a comeback?","volume":"12","author":"Nitzan","year":"2010","journal-title":"Isr Med Assoc J"},{"key":"2022020121021848000_DKU530C82","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1086\/515002","article-title":"The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus","volume":"27","author":"Lautenbach","year":"1998","journal-title":"Clin Infect Dis"},{"key":"2022020121021848000_DKU530C83","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/clinids\/23.4.760","article-title":"Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality","volume":"23","author":"Papanicolaou","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2022020121021848000_DKU530C84","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijantimicag.2011.01.012","article-title":"What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline","volume":"37","author":"Livermore","year":"2011","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/70\/4\/979\/42356065\/jac_70_4_979.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/70\/4\/979\/42356065\/jac_70_4_979.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T15:12:23Z","timestamp":1747408343000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/70\/4\/979\/808124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,11]]},"references-count":84,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,1,11]]},"published-print":{"date-parts":[[2015,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dku530","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,4]]},"published":{"date-parts":[[2015,1,11]]}}}